EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Tumor‐Specific Surface Proteins Enables Quantification of Extracellular Vesicle Subtypes for Early Detection of Pancreatic Ductal Adenocarcinoma

Chen Zhao iD, Zhili Wang, Hyoyong Kim, Hui Kong, Junseok Lee, Jacqueline Ziqian Yang, Anmin Wang, Ryan Y Zhang, Yong Ju, Jina Kim, Bing Feng, Dejun Liu und 16 weitere

Advanced Science · 2025

DOI: 10.1002/advs.202414982 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Chen Zhao und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA, 9009…. Hauptthemen laut MEDLINE: Extracellular Vesicles, Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Early Detection of Cancer. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Science and Technology Foundation of Jiangsu Province, Natural Science Foundation of Hubei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer‐related mortality, largely due to late‐stage diagnosis. Reliable early detection methods are critically needed. PDAC‐derived extracellular vesicles (EVs) carry molecules that reflect their parental tumor cells and are detectable in early disease stages, offering a promising noninvasive diagnostic approach. Here, a streamlined PDAC EV Surface Protein Assay for quantifying PDAC EV subpopulations in 300‐µL plasma through a two‐step workflow is presented: i) click chemistry‐mediated EV enrichment using EV Click Beads and trans‐cyclooctene‐grafted antibodies targeting three PDAC EV‐specific surface proteins (MUC1, EGFR, and TROP2), and ii) quantification of enriched PDAC EVs through reverse transcription‐quantitative polymerase chain reaction. The three PDAC EV‐specific surface proteins are identified using a bioinformatics framework and validated on PDAC cell lines and tissue microarrays. The resultant PDAC EV Score, derived from signals of the three PDAC EV subpopulations, demonstrates robust differentiation of PDAC patients from noncancer controls, with area under the receiver operating characteristic curves of 0.94 in the training ( n = 124) and 0.93 in the validation ( n = 136) cohorts. This EV‐based diagnostic approach successfully exploits PDAC EV subpopulations as novel biomarkers for PDAC early detection, translating PDAC surface proteins into an EV‐based liquid biopsy platform.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesCarcinoma, Pancreatic DuctalPancreatic NeoplasmsEarly Detection of CancerBiomarkers, TumorMembrane ProteinsHumansCell Line, TumorFemaleMale

Stichwörter der Autor:innen

cancer diagnosisextracellular vesiclesliquid biopsypancreatic ductal adenocarcinoma

Substanzen

Biomarkers, TumorMembrane Proteins

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA, 90095, USA.
  • California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA,…
  • Cancer Center, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
  • CAS Key Laboratory for Nano-Bio Interface, Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences, Suzhou, 215123, China.
  • Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
  • Department of Urology and Computational Biomedicine, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.

ORCID-Profile: Chen Zhao, Hsian-Rong Tseng

Förderung

  • NCI NIH HHS
  • Science and Technology Foundation of Jiangsu Province
  • Natural Science Foundation of Hubei Province
  • Youth Innovation Promotion Association CAS
  • NIBIB NIH HHS
  • Youth Innovation Promotion Association of the Chinese Academy of Sciences
  • National Cancer Institute

Zitieren

APA

Zhao, C., Wang, Z., Kim, H., Kong, H., Lee, J., Yang, J. Z., Wang, A., Zhang, R. Y., Ju, Y., Kim, J., Feng, B., Liu, D., Zhang, Y., Wang, Z., Zhang, Y., Guo, S., Gao, D., Tomlinson, J. S., Pei, R., …, & Zhu, Y. (2025). Identification of Tumor‐Specific Surface Proteins Enables Quantification of Extracellular Vesicle Subtypes for Early Detection of Pancreatic Ductal Adenocarcinoma. Advanced Science. https://doi.org/10.1002/advs.202414982

Vancouver

Zhao C, Wang Z, Kim H, Kong H, Lee J, Yang JZ, et al. Identification of Tumor‐Specific Surface Proteins Enables Quantification of Extracellular Vesicle Subtypes for Early Detection of Pancreatic Ductal Adenocarcinoma. Advanced Science. 2025. doi:10.1002/advs.202414982

BibTeX
@article{Zhao2025,
  author = {Zhao, Chen and Wang, Zhili and Kim, Hyoyong and Kong, Hui and Lee, Junseok and Yang, Jacqueline Ziqian and Wang, Anmin and Zhang, Ryan Y and Ju, Yong and Kim, Jina and Feng, Bing and Liu, Dejun and Zhang, Yating and Wang, Zhenfang and Zhang, Yandong and Guo, Shujing and Gao, Dekang and Tomlinson, James S and Pei, Renjun and Wan, Jipeng and Pandol, Stephen J and Sim, Myung-Shin and You, Sungyong and Ma, Ding and Lu, Shaohua and Sun, Na and Tseng, Hsian-Rong and Zhu, Yazhen},
  title = {Identification of Tumor‐Specific Surface Proteins Enables Quantification of Extracellular Vesicle Subtypes for Early Detection of Pancreatic Ductal Adenocarcinoma},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202414982}
}
Kostenlos starten →